Hetero Labs, Ltd. - Unit III recalls Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway,…
- Recall date
- September 12, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1211-2018
- FDA classification
- Class III
- Brand / firm
- Hetero Labs, Ltd. - Unit III
- Sold / distributed
- Indiana and Louisiana
Why it was recalled
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
Get recall alerts
Free email alert whenever Hetero Labs, Ltd. - Unit III has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hetero Labs, Ltd. - Unit III